Cooley LLP announced today that it advised the underwriters on Onconova Therapeutics, Inc.’s initial public offering. Onconova is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Onconova now trades on the NASDAQ Global Stock Market under the symbol “ONTX.”
Citigroup Global Markets Inc. and Leerink Swann LLC acted as joint book-running managers for the offering; Piper Jaffray & Co. and Janney Montgomery Scott LLC acted as co-managers.
The Cooley corporate securities team advising the underwriters was led by partner Drew Williamson and included partner Brent Siler, special counsel Brian Leaf and associate Robert E. Jones. Critical support for the offering was provided by partner Bill Christiansen (intellectual property); partners Natasha Leskovsek and Andrew Gantt and associate David Sclar (regulatory); partner Ken Krisko and associate Jennifer Raab (life sciences) and partner Susan Cooper Philpot (tax).
According to American Lawyer‘s 2012 Corporate Scorecard, Cooley served as issuer counsel on 40 US equity offerings, ranking as the most active law firm advising issuers in the country. Cooley was also ranked as the third most active law firm advising underwriters on US IPOs.
Related Posts:
- Dermira Prices its Initial Public Offering
- Cooley Advises Underwriters on Receptos, Inc. Initial Public Offering
- Invitae Completes $117 Million Initial Public Offering
- Atara Completes its Initial Public Offering
- Cooley Advises Underwriters on Epizyme, Inc. Initial Public Offering
